Skip to content

MindfulGarden in Treatment of Hyperactive Delirium in a Hospital Setting

A Pilot Study of an Interactive Digital Technology (MindfulGarden) in Treatment of Hyperactive Delirium in a Hospital Setting

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03621228
Enrollment
24
Registered
2018-08-08
Start date
2018-09-30
Completion date
2019-04-30
Last updated
2018-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperactive Delirium

Keywords

Delirium, Hyperactive, Aggression, Anxiety, Digital therapy

Brief summary

This pilot study is designed to address feasibility for a larger randomized control clinical study that will determine the efficacy of exposure to the MindfulGarden - an interactive digital technology - in reducing hyperactive delirium in hospitalized older adults.

Detailed description

The primary objective of the study is to establish whether the key components necessary for conducting a full randomized control study in the future, such as recruitment, consent, randomization, and treatment processes are working well and all function together. As a secondary objective, the investigators will determine trends in patients exposed to MindfulGarden (MG), for example: 1. At the first and second administration of the Confusion Assessment Method - short form (CAM) after admission to a medical ward are there more, the same or fewer patients in the intervention group than in the control group whose CAM scores change from positive to negative? 2. During the first 24 hours after admission to a medical ward, did fewer, the same, or a greater number of patients in the intervention than in the control group experience significant events/alerts (e.g. aggressive/violent behaviours, falls, code white)? 3. During the first 24 hours after admission to a medical ward, were fewer, the same, or a greater number of patients in the intervention than in the control group administered psychotropic drugs (e.g. haloperidol, risperidone, quetiapine, lorazepam)? were more, the same, or fewer administered sleeping aids (e.g. trazodone, melatonin)? 4. During the first 24 hours after admission to a medical ward, were fewer, the same, or a greater number of patients in the intervention than in the control group physically restrained? 5. Was mean length of stay from time of admission to a medical ward until discharge due to death, return to place of residence before admission or to a different place of residence longer, the same or shorter in the intervention than in the control group? 6. Were there more, the same or fewer deaths or discharges to a higher level of care (e.g. to assisted living, to a complex care facility in patients who previously lived at home) in the intervention than the control group? Additionally, to the extent that movement and vocalization are reflective of anxiety, agitation and/or aggression (i.e. responsive behaviours) the investigators also want to determine whether there is a correlation between changes in these as recorded by the MG and any of the indicators listed in 1-6 above.

Interventions

DEVICEMindfulGarden

MindfulGarden (MG) is an interactive digital technology that combines use of a smart television with sensors to intelligently generate content based on patient voice and gesture input, triggering a multi-layered visual 'garden' on-screen to arrest and de-escalate anxiety and aggression in treatment of hospitalized elderly diagnosed with hyperactive delirium.

Sponsors

Simon Fraser University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- All patients aged 65 years or older admitted to the Emergency Department who have a diagnosis of hyperactive delirium as defined by the short CAM

Exclusion criteria

* Patients with severe vision impairment or who are legally blind * Patients for whom a bed in a medical ward was not available within 12 hours of a diagnosis of hyperactive delirium (i.e. who remained in the Emergency Department more than 12 hours)

Design outcomes

Primary

MeasureTime frameDescription
Recruitment RatesNumber enrolled within 12 hours of admission to Emergency DepartmentNumber of participants approached and their rate of consent

Secondary

MeasureTime frameDescription
Estimate the potential effect size24-hour period following transfer from Emergency DepartmentMG association with reducing delirium duration as measured CAM - short
Adverse Outcomes (number of patients with aggressive/violent behaviours, falls, code white)24-hour period following transfer from Emergency DepartmentAssess from patients medical chart
Psychotropic Drug Consumption24-hour period following transfer from Emergency DepartmentAssess from patient's medical chart
Application of Physical Restraints24-hour period following transfer from Emergency DepartmentAssess from patient's medical chart
Length of StayDate of study enrolment through to discharge from hospital, or date of study enrolment up to 30 daysAssess from patient's medical chart

Contacts

Primary ContactGloria Gutman, PhD
gutman@sfu.ca778.782.5063
Backup ContactFabio Feldman, PhD
fabio.feldman@fraserhealth.ca6045877850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026